EV/EBITDA
0.32
-0.05-13.51%
Tue, 31 Dec 2024 14:30:00 GMT
Summary:
Galera Therapeutics EV/EBITDA is currently 0.32, with a fall of -0.05 (-13.51%) during the most recent trading day. Over the past year, it has increased by +0.13 (+68.42%). GRTX EV/EBITDA is now -13.51% below its all-time high of 0.37.GRTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -13.5% |
| 1 m1 month | -5.9% |
| 3 m3 months | +33.3% |
| 6 m6 months | +300.0% |
| ytdytd | +68.4% |
| 1 y1 year | +68.4% |
| 5 y5 years | +105.0% |
GRTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.37 | -13.5% | 0.32 | at low |
| 3 m | 3 months | 0.37 | -13.5% | 0.23 | +39.1% |
| 6 m | 6 months | 0.37 | -13.5% | 0.07 | +357.1% |
| 1 y | 1 year | 0.37 | -13.5% | -0.02 | +1700.0% |
| 3 y | 3 years | 0.37 | -13.5% | -2.42 | +113.2% |
| 5 y | 5 years | 0.37 | -13.5% | -8.65 | +103.7% |
| alltime | all time | 0.37 | -13.5% | -8.65 | +103.7% |
Galera Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 0.32(+68.4%) |
| 2023 | 0.19(-125.0%) |
| 2022 | -0.76(-45.7%) |
| Date | Value |
|---|---|
| 2021 | -1.40(-59.8%) |
| 2020 | -3.48(-45.2%) |
| 2019 | -6.35 |
FAQ
- What is Galera Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Galera Therapeutics?
- What is GRTX EV/EBITDA year-to-date change?
- What is Galera Therapeutics EV/EBITDA year-on-year change?
What is Galera Therapeutics EV/EBITDA?
The current EV/EBITDA of GRTX is 0.32
What is the all time high EV/EBITDA for Galera Therapeutics?
Galera Therapeutics all-time high EV/EBITDA is 0.37
What is GRTX EV/EBITDA year-to-date change?
Galera Therapeutics EV/EBITDA has changed by +0.13 (+68.42%) since the beginning of the year
What is Galera Therapeutics EV/EBITDA year-on-year change?
Over the past year, GRTX EV/EBITDA has changed by +0.13 (+68.42%)